Azathioprine
Azacitidine
A pyrimidine analogue that inhibits DNA methyltransferase, impairing DNA methylation. It is also an antimetabolite of cytidine, incorporated primarily into RNA. Azacytidine has been used as an antineoplastic agent.
Molecular Structure
Immunosuppressive Agents
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
Sulfur Compounds
Spiro Compounds
Volatile Organic Compounds
6-Mercaptopurine
Structure-Activity Relationship
Small Molecule Libraries
Dose-Response Relationship, Drug
Plant Extracts
Benzamidines
Drug Evaluation, Preclinical
Furans
Methyltransferases
Magnetic Resonance Spectroscopy
Heterocyclic Compounds
Inhibitory Concentration 50
Marine Toxins
Organotin Compounds
Cyclosporine
Chromatography, High Pressure Liquid
DNA Methylation
Addition of methyl groups to DNA. DNA methyltransferases (DNA methylases) perform this reaction using S-ADENOSYLMETHIONINE as the methyl group donor.
Enzyme Inhibitors
Stereoisomerism
Drug Design
The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis.